Foster City · Pre-Seed–Late Stage · 40 people tracked
Also known as IIF MANAGEMENT COMPANY, LLC
Investment thesis
Illumina Ventures positions itself as a leader in genomics and precision health investing. The firm concentrates on building the broader ecosystem around these fields and translating capital into innovation, with the stated goal of accelerating positive impact on human health.
Source: firm website, verified Aug 25, 2026.
Team · 40 people
from the firm's website & public directories
Founder mafia
4 people who came through Illumina Ventures went on to found or lead other companies.
What they invest in
from 43 of 50 portfolio companiesBiotech ×40Healthtech ×17Deep Tech ×14AI & Machine Learning ×13Digital Health ×10Medical Devices ×10AgTech ×2Hardware ×2
HQs:United States×27Sweden×1
Who they back
founder profiles across 29 portfolio companiesFounding team size:solo founder×142 founders×73 founders×64+ founders×2
Where their founders studiedfrom 10 founders with education data
Massachusetts Institute of Technology ×2
Where their founders worked beforefrom 12 founders with career history
Massachusetts Institute of Technology ×3Brigham and Women's Hospital ×2Harvard Medical School ×2Harvard University ×2
Investments · 50 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 12024 · 12022 · 32021 · 19 dated
Castle Biosciences develops genomic diagnostic tests that use a patient's molecular biology to inform disease management and treatment decisions.
BiotechDigital HealthHealthtechFriendswood, US
Derek Maetzold(Executive Officer, Director)inDerek J. Maetzold(Founder, President & Chief Executive Officer)Frank Stokes(Chief Financial Officer)Kristen Oelschlager(Chief Operating Officer)Toby Juvenal(Chief Commercial Officer)Hillary Caruso(Chief of Staff)
Co-investorsBioBritMountain Group Capital
Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps.
BiotechHealthtechMedical DevicesAustin, US
Nick Arab(Founder & CTO)Ross Johnson(Co-founder & Chief Engineer)Carey-Ann Burnham(Chief Executive Officer)Travis Davies(SVP, Operations)Kyle Fieleke(SVP, Corporate Development & Finance)David Bussian(SVP, Clinical, Regulatory & Assay Development)
Co-investorsAMR Action Fund
Pluton is developing a sun-powered, soil-surface biological nutrient system that uses photosynthetic microbial consortia to fix atmospheric nitrogen, improve phosphorus availability, and add carbon to soil for crop growers.
AgTechBiotechClimate TechSt. Louis, US
Barry Goldman(Co-founder)Elizabeth Gallegos(Chief Executive Officer)Jerry Steiner(Executive Chair)Charlie Walch(Executive Officer, Director)Glendon Schuster(Director)
Co-investorsFirst In VenturesRadicle GrowthBetter VenturesFall Line CapitalGrantham FoundationRA Capital+4 more
Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials.
AI & Machine LearningBiotechDigital HealthBoston, US
Rehan Verjee(Co-Founder, Chief Executive Officer, Board Director)Sylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)Toni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)
Co-investors5AM VenturesOUP (Osage University Partners)Lilly Asia VenturesOsage University Partners
Predicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response.
BiotechDigital HealthMedical DevicesCambridge, US
Irene Ghobrial(Co-founder)Kenneth Anderson(Co-founder)Gad Getz(Co-founder)Romanos Sklavenitis-Pistofidis(Co-founder)Keith Flaherty(Co-founder)Brian McKernan(CEO)
Co-investorsThe Engine Ventures
RedShiftBio develops analytical technology that provides real-time measurement of biomolecular structure and concentration, aimed at supporting decisions in biopharmaceutical development and manufacturing.
BiotechDeep TechHardwareBoxborough, US
Thomas O'Lenic(Executive Officer, Director)Eugene Ma(Executive Officer)Charles Marshall(Executive Officer, Director)Don Bossi(Director)
BoardFrank Smith(Director)inWilliam Cadogan(Director)
Co-investorsTechnology Venture Partners
Actym Therapeutics engineers bacteria as a delivery system for therapeutics targeting cancer and fibrotic disease.
BiotechHealthtechBerkeley, US
Christopher D Thanos(Executive Officer, Director, Promoter)Kanad Das(Director)Amit Kumar(Director, Promoter)James Huang(Director)
Adventris is a biotechnology company developing cancer immunotherapy treatments.
BiotechHealthtechBaltimore, US
Jen Herbach(Founder)inWilliam Collis(Founder)inMark Yarchoan(Founder)
Co-investorsY CombinatorRefactor Capital
Alamar Biosciences develops NULISA, an ultra-high-sensitivity, high-specificity technology for analyzing hundreds of protein biomarkers from small biofluid samples, building on the team's prior spatial genomics work (RNAscope).
BiotechDeep TechHealthtechFremont, US
Yuling Luo(Co-founder, CEO and Chair)Steve Chen(Co-founder, COO and Director)Yiyuan Yin(Co-founder, VP of Technology)Tod White(President)Justin McAnear(CFO)inXiao-Jun Ma(CTO)
Co-investorsQiming Venture PartnersSamsara BioCapital
Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.
BiotechDigital HealthMedical DevicesCambridge, US
DAVID ARTHUR SCOTT(Executive Officer)WINSTON XIA YAN(Executive Officer)FENG ZHANG(Director)ANNIE HAZLEHURST(Director)
BoardKEITH CRANDELL(Director)DAVID R. WALT(Director)in
Co-investorsARCH Venture PartnersOno Venture Investment, Inc.TCG CrossoverThird Rock Ventures
Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with 3D genome structural information (via Hi-C sequencing) to detect fusions, rearrangements, ecDNA, and other structural drivers of cancer.
BiotechHealthtechMedical Devices
Sid Selvaraj(Founder & Chief Operating Officer)Tom Willis(Chief Executive Officer)Anthony Schmitt(Senior Vice President, Science)Erin Davis(Vice President, Marketing)
Co-investorsBerkeley Catalyst
Attovia is a biotechnology company focused on drug development and clinical strategy, aiming to bring treatments to patients where none exist and create next-generation therapeutic options.
BiotechDigital Health
Zaneta Odrowaz(Founder)in
Co-investorsEcoR1 CapitalFrazier Life SciencesNextech InvestSanofi VenturesVida VenturesGoldman Sachs
Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks.
AI & Machine LearningBiotechDeep Tech
Co-investorsFirst In VenturesHeran PartnersKorysMérieux Equity Partners
Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation.
BiotechDeep Tech
Corey Gray(Co-founder and CEO)Michael McKeown(Co-founder and Head of Research)
Co-investorsZAKA VC
BiotechPittsburgh, US
Michael Hoerres(Executive Officer, Director)
BoardJames Peters(Director)Steve Grenfell(Director)Paul Schmitt(Director)Noel Doheny(Director)
CubaseBio develops spatial biology tools that enable three-dimensional analysis of biological samples at scale, for drug discovery and biological research.
BiotechDeep TechStockholm, SE
Paulius Mielinis(Founder)Toon Verheyen(Founder)Xiaoyan Qian(Founder)
Co-investorsLeksell Social VenturesNordic Science InvestmentsVoima Ventures
DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US
Victor Velculescu(Executive Officer, Director, Promoter)Peter Bach(Executive Officer)Jennifer Buechel(Executive Officer)Douglas Schenkel(Executive Officer)Nicholas Dracopoli(Executive Officer)
BoardRishi Gupta(Director)in
Co-investorsAV8 VenturesForesite CapitalMenlo VenturesOpen Field CapitalOrbiMedOUP (Osage University Partners)+3 more
Encoded develops gene therapies for neurological disorders through an integrated platform approach.
Biotech
Stephanie Tagliatela(Founder)in
Co-investorsARCH Venture PartnersBioBritGV (Google Ventures)Menlo VenturesSoftBank Vision FundVenrock
Fluent Bio develops software for analyzing single-cell RNA sequencing data, producing count matrices and diagnostic outputs for researchers using Illumina sequencing libraries.
BiotechDeveloper Tools
Co-investorsCivilization Ventures Management, LlcCota CapitalSamsara BioCapital
Fuze Health operates a unified digital healthcare platform spanning digital pharmacy (FuzeRx), clinical services such as diagnostics, screening and genetics (Fuze Services), and data and technology tools (Fuze Technologies).
AI & Machine LearningDigital HealthHealthtechSaaS
Co-investorsHLM Venture PartnersK2 HealthVenturesOlive Tree CapitalSoftBank Vision FundTowerBrook
Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.
BiotechDigital HealthHealthtech
Mark Sylvester(Chief Financial Officer)Andrew Warner(Vice President, Product)Monica Zarb(Vice President, Business Development)Durand Van Arnem(Vice President, Engineering)Alan Rope(Medical Director)
Co-investorsCanaan PartnersDreamers VCEcho Health VenturesGV (Google Ventures)Kaiser Permanente VenturesSamsung Catalyst Fund+3 more
Provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and access to clinical trial opportunities, with a focus on rare conditions.
BiotechDigital HealthHealthtech
Co-investorsiSelect FundCanaan Partners
Hepta develops LiquidTransformer, an AI platform for analyzing cell-free DNA fragments in blood to detect chronic disease molecular signals.
AI & Machine LearningBiotechHealthtechSan Francisco, US
Hamed Amini(Founder)inSoheil Damangir(Founder)
Co-investorsAlumni VenturesAME Cloud VenturesFelicis VenturesSeaX Ventures
Iambic develops AI technologies for drug discovery, using a high-throughput experimental platform to design small-molecule medicines and advance a pipeline of clinical candidates for cancers such as HER2-driven, breast, and ovarian tumors.
AI & Machine LearningBiotechDeep TechSan Diego, US
Tom Miller(Co-Founder & CEO)inFred Manby(Co-Founder & CTO)inThomas Miller(Founder)inNeil Josephson(Chief Medical Officer)inPete Olson(Chief Scientific Officer)inMichael Secora(Chief Financial Officer and Chief Corporate Development Officer)in
Co-investorsAbingworthAscenta CapitalCatalio Capital ManagementAlumni VenturesCatalio Capital Management, LPCoatue Management+4 more
Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins.
BiotechDeep TechHealthtechBaltimore, US
Benjamin Larman(Executive Officer, Director)inJoy M Nassif(Executive Officer, Director)Joy Nassif(Executive Officer, Director)
BoardMatthew Hellauer(Director)Herman Scholtz(Director)inCaroline Popper(Director)in
Co-investorsTCP Venture CapitalPTX Capital
Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology.
AI & Machine LearningBiotechLongevityRedwood City, US
Felix Wong(Executive Officer, Director)inThemasap Khan(Director)Daniel J. Anderson(Chief Scientific Officer)
BoardKeith Loebner(Director)
Co-investorsSutter Hill VenturesCivilization Ventures Management, Llc
Kallyope is a biotechnology company founded by neuroscientists that discovers and develops novel therapeutics targeting neural networks, with a lead candidate in pivotal studies for acute migraine treatment and metabolism programs approaching clinical studies.
BiotechHealthtechNew York City, US
Tom Maniatis(Director)Nancy Thornberry(Executive Officer, Director)Kenneth Clark(Executive Officer)
BoardTerry McGuire(Director)inJoshua Wolfe(Director)inTim Kutzkey(Director)
Co-investorsDns CapitalLux CapitalThe Column GroupPolaris Partners
Kodikaz develops Zip-Code, a non-viral cell-specific delivery platform for gene therapy applications, particularly focused on oncology and cancer treatments.
AI & Machine LearningBiotechMedical DevicesAtlanta, US
Anthony Johnson(Co-Founder & CEO)inDr. Leon Bernal-Mizrachi(Co-Founder, CSO)in
Co-investorsEpidarex CapitalGRA Venture
Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.
BiotechDeep TechHealthtech
Co-investors+ND CapitalLongwall Venture Partners LLPM VenturesOMX VenturesARCH Venture Partners
Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale.
BiotechDeep TechMedical Devices
Co-investorsARCH Venture PartnersPerscitus LLP
NanoCellect develops microfluidic-based cell sorters that operate at low pressure to sort cells with high viability and reduced shear stress, aimed at scientists and researchers.
BiotechHardwareMedical Devices
Chris Neary(CEO)in
Co-investorsVertical Venture PartnersWarburg PincusFusionX Ventures
NuCicer develops improved crop varieties through selective breeding, starting with high-protein chickpeas designed for better nutrition.
AgTechAI & Machine LearningFoodTechDavis, US
Kathryn Cook(Executive Officer, Director)inDouglas Cook(Executive Officer, Director)
BoardPaimun Amini(Director)inJerry Steiner(Director)inCarsten Boers(Director)in
Co-investorsBetter Ventures Central LlcBlue Horizon CorporationLever VCRhapsody Venture PartnersStray Dog Capital
Oncko develops machine learning and experimental platforms to discover optimized multi-drug cancer treatment combinations by screening against resistance mechanisms.
AI & Machine LearningBiotechDeep Tech
Atray Dixit(Co-founder, CEO)inBill Grossman(Co-founder, Strategic Advisor)in
Co-investorsAdverb VenturesTenmile
Developing a diagnostics platform using single-cell analysis and machine learning to rapidly identify bacterial pathogens and determine antibiotic susceptibility.
Co-investorsAMR Action Fund
BiotechAustin, US
Carey-Ann Burnham(Executive Officer, Director)Nicolas Arab(Executive Officer, Director)Johnson Ross(Executive Officer)Bryan Gammon(Director)Oscar Marx(Director)
BoardJunjun Gao(Director)
Co-investorsAMR Action FundIllumina Innovation
Provides insights by analyzing data and content about brands on the internet.
Mcminnville, US
Dale Djerassi(Director)Brian Feucht(Executive Officer)
BoardRoger Lang(Executive Officer, Director)in
Co-investorsInspiration VenturesCerraCap VenturesThe Engine Ventures
Protillion Biosciences develops platform technology for antibody engineering and drug discovery.
AI & Machine LearningBiotechDeep TechCarlsbad, US
Curtis Layton(CEO/Co-Founder)inDavid Walt(Co-Founder)inWill Greenleaf(Co-Founder)inRobert Hollingsworth(Chief Scientific Officer)in
BoardSean Kendall(Director)inMalek Faham(Director)in
Co-investorsARCH Venture Partners
Santa Clara, US
Jekwan Ryu(Executive Officer, Director)Ronald M. Cook(Director)Eric Williams(Executive Officer)Tae Hoon Nahm(Director)
BoardTom Willis(Director, Executive Officer)
BiotechGreenville, US
Kevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)
Co-investorsM VenturesMC Healthcare VenturesPappas CapitalSV Health InvestorsDementia Discovery FundHatteras Venture Partners+1 more
Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.
BiotechHealthtechNew York City, US
Adam Yaari(Founder/CEO)inMaxwell Sherman(Founder/CTO)in
Co-investorsMetaplanetY Combinator
HealthtechCambridge, US
Rahul Dhanda(Executive Officer, Director)James Collins(Director)David Walt(Director)in
BoardIssi Rozen(Director)in
Co-investorsCatalio Capital Management, LPGV (Google Ventures)
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.
BiotechDeep TechHealthtechSouth San Francisco, US
Kenneth Greenberg(Co-Founder, President & CEO)in
Co-investorsVida VenturesLeaps by BayerFoothill VenturesMedical Excellence CapitalVivo CapitalARCH Venture Partners+1 more
Co-investorsKurma Partners
Syntax Bio develops a discovery platform that accelerates stem cell-derived therapies by using its proprietary Cellgorithm technology to control and direct cell differentiation.
BiotechDeep TechMedical Devices
Ryan Clarke(Founder)in
Co-investorsAstellas Venture Management LLCDCVC (Data Collective)DCVC BioDraper AssociatesPortal Innovations
Tagomics is focused on organ health, though the available page content does not provide enough detail about its products, technology, or business model.
BiotechMedical Devices
Co-investorsCalculusCalculus Capital Ltd.IQ CapitalMEIF Proof-of-Concept & Early Stage FundMercia VenturesOMX Ventures+1 more
Exits · 1
IPOs and acquisitions across the tracked portfolioCastle BiosciencesNASDAQ: CSTL
Portfolio news
latest coverage across their companiesAttovia Therapeutics · medicaldialogues.in · Jul 19, 2026
SonoThera · statnews.com · Jul 17, 2026
Pattern · investing.com · Jul 14, 2026
Iambic · geekwire.com · Jul 13, 2026
Delfi Diagnostics · geekwire.com · Jul 13, 2026
Lightcast · kb.lightcast.io · Jul 2, 2026
Syntax · bizjournals.com · Jun 23, 2026
Protillion Biosciences · genengnews.com · Jun 18, 2026
Frequently asked questions
- How many investments has Illumina Ventures made?
- Illumina Ventures has 45 tracked investments, including 4 dated in the last 24 months.
- What stage does Illumina Ventures invest at?
- Illumina Ventures invests at the Pre-Seed, Seed, Series A, Late Stage stages.
- What sectors does Illumina Ventures focus on?
- Illumina Ventures focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Illumina Ventures located?
- Illumina Ventures is headquartered in Foster City, US.
- Does Illumina Ventures lead rounds?
- Illumina Ventures typically participates in rounds rather than leading them.
- Who does Illumina Ventures co-invest with?
- Illumina Ventures most often shares deals with ARCH Venture Partners, Samsara BioCapital, GV (Google Ventures), among 84 tracked co-investors.
Co-investors · 11
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Kurma Partners is a European healthcare-focused investment firm that co-founds and finances biotech and healthcare companies, working closely with research centers to translate scientific discoveries into high-tech companies.
Qiming Venture Partners is a Shanghai-based venture capital firm that invests in growth-stage technology, communications, media, and healthcare companies operating in China, with support from its U.S. partner Ignition Partners. The firm's investment approach combines local market knowledge with global resources and executive relationships.
+ND Capital is an investment firm founded in 2002 focused on nanotechnology and deep science ventures, backing companies emerging from breakthroughs at the nanoscale.
Catalio is a software platform that uses AI to automatically extract and document business logic from legacy and modern systems, creating living specifications that stay current as software evolves.
Transformation Capital is an investment firm focused exclusively on the healthcare industry, backing companies transforming healthcare delivery and services.
Paladin Capital Group invests in early stage and growth companies developing cyber, AI and deep technologies that address security and resilience needs for commercial and government customers.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Genoa Ventures is a venture capital firm that works with strategic partners providing market insights, validated deal flow, and domain expertise to support its portfolio companies.
Casdin Capital is an investment firm focused on the life sciences, investing across healthcare, biotechnology, synthetic biology, and related technology.
Firms observed investing alongside Illumina Ventures, from public investor directories. Shared companies are the overlap with Illumina Ventures's recorded portfolio.
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.